Rational design of cyanobacteria aptamer sensitizes prostate cancer to hormone therapy
We performed RNA-seq to investigate gene expression changes in prostate cancer cells  treated with L-Gln and 56 mer Gln aptamer Overall design: RNA-seq was performed in C4-2B and 22RV1 cells with biological triplicates under various conditions (56 mer 50 nM and L-Gln 2 mM).